Kidney and Cardiovascular Effectiveness of Empagliflozin Compared With Dipeptidyl Peptidase-4 Inhibitors in Patients With Type 2 Diabetes.
Edmonston D, Mulder H, Lydon E, Chiswell K, Lampron Z, Shay C, Marsolo K, Jones WS, Butler J, Shah RC, Chamberlain AM, Ford DE, Gordon HS, Hwang W, Chang A, Rao A, Bosworth HB, Pagidipati N.
Edmonston D, et al. Among authors: chiswell k.
Am J Cardiol. 2024 Jun 15;221:52-63. doi: 10.1016/j.amjcard.2024.04.011. Epub 2024 Apr 17.
Am J Cardiol. 2024.
PMID: 38641191